Internal Medicine, Hematology & Oncology · Orange, CA
NPI
1245281211
Since 2006
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
230 S. Main St, Suite 100
Orange, CA, 92868
Phone (714) 541-0101
Groups this clinician bills Medicare through
Medicare paid, 2024
$250K
9,894 services
Medicare patients, 2024
472
Average age 75
Drug cost, 2024
$218K
517 prescriptions
Company payments, 2025
$68.92
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by John S Link was code J0897 (injection, denosumab, 1 mg), 5,280 times for 24 patients. In total John S Link billed 9,894 services in 21 codes, and Medicare paid $250K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-05-26.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 5,280 | 24 | $20.91 | $110K |
| J9395 Injection, fulvestrant, 25 mg | Office | 2,640 | 30 | $6.24 | $16K |
| 99214 Office E&M - Established | Office | 863 | 426 | $98.31 | $85K |
| 96402 Chemotherapy Administration | Office | 267 | 33 | $31.42 | $8,389 |
| 36415 Venipuncture Blood Collection | Office | 168 | 100 | $5.88 | $988 |
| 99213 Office E&M - Established | Office | 94 | 74 | $75.84 | $7,129 |
| 96372 Injection Administration | Office | 73 | 27 | $12.27 | $896 |
| 99204 Office E&M - New | Office | 19 | 19 | $135.62 | $2,577 |
| 99205 Office E&M - New | Office | 12 | 12 | $187.63 | $2,252 |
By year: 2022 $184K for 7,218 services; 2023 $184K for 7,029 services; 2024 $250K for 9,894 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 168 | 100 | $5.88 | $988 |
Medicare prescription drug claims, 2024
In 2024, the drug John S Link prescribed most often to Medicare patients was Tamoxifen Citrate, with 185 prescriptions and refills. In total John S Link wrote 517 Medicare prescriptions that cost $218K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tamoxifen Citrate Generic | 185 | 303 | 60 | $2,620 |
| Raloxifene Hcl Generic | 67 | 134 | 27 | $2,696 |
| Duavee Estrogens,conj/Bazedoxifene | 56 | 68 | 18 | $14K |
| Estradiol Generic | 34 | 84 | 20 | $3,113 |
| Exemestane Generic | 21 | 31 | Under 11 | $1,911 |
| Letrozole Generic | 14 | 40 | Under 11 | $394 |
| Dotti Estradiol | 14 | 17 | Under 11 | $957 |
| Oxybutynin Chloride Er Oxybutynin Chloride | 14 | 26 | Under 11 | $375 |
| Veozah Fezolinetant | 12 | 12 | Under 11 | $6,283 |
| Anastrozole Generic | 11 | 24 | Under 11 | $117 |
Brand drugs: 98 claims; generic drugs: 419 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid John S Link $68.92 ($68.92 in general payments such as food, travel and fees) from 2 companies. The largest payer was Boston Scientific Corporation with $42.05.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.